This month marks a major milestone for our Rosalind Study: 115+ clinical research centers are now actively participating across France and internationally. With expansion underway, our international oncology network is on track to include centers in 63 countries, accelerating progress in outlier patient research and precision oncology.
We are building a global network where every center counts, because every patient counts:
From one outlier patient to several dozen
From leading university hospitals to dedicated community centers
From a single cohort to all three study cohorts
From France to a rapidly growing global clinical research network
Every contribution strengthens the Rosalind Study and advances our mission to unlock new treatments from exceptional patient responses.
The Driving Force: Clinical Research Collaboration
Internal and external collaboration is the beating heart of our Rosalind Study.
A special thank you to our Clinical Research Associates (CRAs), whose work is essential to the success of this retrospective oncology study. By building strong partnerships with participating sites, communicating the scientific stakes and ensuring strict adherence to clinical research best practices including GDPR compliance, they give meaning to every data point collected. We also extend our deepest gratitude to every hospital and research center team involved. Because the study is retrospective and exploratory, it requires:
Meticulous patient screening
Multiple levels of quality control (Q/C)
Exceptional commitment from clinical teams
Reaching 115+ participating centers is just the beginning.
Join Cure51’s Global Clinical Research Network
We are continuing to expand our international oncology network to accelerate discoveries for patients worldwide.
Want to join our international oncology network? Contact our clinical network team!
Lead Partner Oncology Centres
• Centre Léon Bérard (CLB)
• Vall d'Hebron Institute of Oncology (VHIO)
• Charité Universitätsmedizin Berlin
• Institut Gustave Roussy (IGR)
Partner Oncology Centres Worldwide
NTUH (Taiwan), SKMCH&RC - Shaukat Khanum Memorial Cancer Hospital (Pakistan), Well Cornell, Addenbrooke's Hospital – Cambridge (NHS), AP-HP, Beaujon, Paul Brousse, Saint Antoine, Henri Mondor, La Pitié Institut Bergonié (Unicancer), MedicalPark Florya, Hacettepe University Cancer Institute, The Clatterbridge Cancer Centre – Liverpool (NHS), Memorial Hospital Antalya, American Hospital Dubai, University Hospitals Dorset – Dorset (NHS), Trakya University Hospital, Polyclinique de l'Ormeau, Dicle University, Hoag, Van Yüzüncü Yıl University, IPO Lisboa, OSR - Ospedale San Raffaele Milano (IRCCS), Avera Cancer Institute, GHM-Grenoble, AOUI Verona, INEC - Instituto de Neurocirurgia, Universiti Malaya Medical Centre, Royal Surrey NHS Foundation Trust, CH de Blois, Hospital CUF Tejo, CHU Orléans, Caucasus Medical Center, Bahrain Oncology Center, Chelsea and Westminster Hospital – London (NHS), Mediclinic City Hospital Dubai, CH le Mans, Hospital da Luz, Leeds Teaching Hospitals – Leeds (NHS), Institute of Oncology of Ljubljana, CHL - Centre Hospitalier de Luxembourg, Auna Ideas - COLOMBIA, NCCS - National Cancer Center Singapore, St. Olavs Hospital, CHU Reims, Tel Aviv Sourasky Medical Center / Ichilov, HUB - Hôpital Universitaire de Bruxelles, CH Albi, CEMIC, University Hospital Southampton – Southampton (NHS), FLENI, HUS - Helsinki University Hospital, Institut Godinot (Unicancer), HGPR - Jason Sendwe, Singleton Hospital – Swansea – Wales (NHS), CH Toulon, Hadassah, Soroka Medical Center, Velindre University – Cardiff – Wales (NHS), CH Pau, SOHEC - Sociedad de Oncología y Hematología del Cesar, CHU Nantes, Tel HaShomer - Sheba Medical Center, Grampian – Aberdeen – Scotland (NHS), RMH - The Royal Marsden – London (NHS), Hôpital Saint-Antoine (AP-HP), UHB - University Hospitals Birmingham – Birmingham (NHS), Haukeland University Hospital, NNUH – Norfolk and Norwich University Hospitals – Norwich (NHS), FJD - Fundacion Jimenez Diaz, The Christie – Manchester (NHS), Hopital Abderrahmen Mami, Centre Eugène Marquis (Unicancer), MMCI - Masaryk Memorial Cancer Institute, Barts Health – London (NHS), Metropolitan Hospital, CHU Lille, ICL - Institut de Cancérologie de Lorraine, Centre Jean Perrin (Unicancer), IICIMED - Instituto de Investigación en Ciencias Médicas, Infanta Sofia Hospital, La Paz - Instituto de Investigación Hospital Universitario, Onco Tech, Unity Health Toronto, UNEOS - Hôpital Robert Schuman (Unicancer), CHCB - Centre Hospitalier de la Côte Basque (Unicancer), KHCC - King Hussein Cancer Center, CGFL - Dijon (Unicancer), Hôpital Clairval (Ramsay Santé), Hôpital Privé Jean Mermoz (Ramsay Santé), CHANGE - CH Annecy Genevois, Hôpital Foch, CH Carcassonne, Hospital del Mar, TUH - Tartu University Hospital, CIO Medic, INEN - Instituto Nacional de Enfermedades Neoplasicas, VHIO - Vall d'Hebron Institute of Oncology, ICAP – Institut du Cancer Avignon-Provence (Sainte Catherine Unicancer)
Updated: February 18, 2026
